EQL Pharma – information regarding disclosure notice and mandatory offer from Fårö Capital AB
Fårö Capital AB (“Fårö Capital”), a company controlled by Christer Fåhraeus, board member and CEO of EQL Pharma AB (publ) (“EQL Pharma”), has on March 19th, 2019 through separate press releases published a disclosure notice through which Fårö Capital announces that Fårö Capital has acquired shares so that the limit for a mandatory offer has been achieved; and a cash mandatory offer to the shareholders of EQL Pharma. The board of directors of EQL Pharma will now evaluate the mandatory offer from Fårö Capital.In the disclosure notice published by Fårö Capital on March 19th, 2019, it is stated